Drugs / sodium divalproate
last change Jan 2007 re-read 3 minutes ago

sodium divalproate

also known as DEPAKOTE
Developed for
bipolar disorder
Investigated by
Sanofi

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00271258 Jan 2005 → Jan 2007 bipolar disorder Sanofi Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as sodium divalproate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00271258 ↗
Known as DEPAKOTE “STUDY OF THE TOLERANCE OF SODIUM DIVALPROATE (DEPAKOTE) IN ADOLESCENTS IN MANIC, MIXED OR HYPOMANIC EPISODES OF BIPOLAR DISORDER” NCT00271258 ↗